Report cover image

Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Aug 26, 2024
Length 83 Pages
SKU # GBDT19176690

Description

Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Vagus Nerve Stimulators (VNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Vagus Nerve Stimulator is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically implanted electrodes to target the vagus nerve. VNSs are utilized to treat neurological disorders such as epilepsy and depression.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vagus Nerve Stimulators (VNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

83 Pages
    • Vagus Nerve Stimulators (VNS) Overview
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Segment
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
    • Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
    • Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
    • Adriakaim Inc Company Overview
    • Bionics Institute Company Overview
    • Boston Scientific Corp Company Overview
    • DuoCure Ltd. Company Overview
    • ElectroCore Inc Company Overview
    • LivaNova PLC Company Overview
    • LivaNova USA Inc Company Overview
    • MicroTransponder Inc Company Overview
    • Neurive Inc Company Overview
    • Neuroloop Gmbh Company Overview
    • Nexeon MedSystems Inc Company Overview
    • Otto Bock HealthCare GmbH Company Overview
    • Purdue University Company Overview
    • ReShape Lifesciences Inc Company Overview
    • Setpoint Medical Corp Company Overview
    • Synergia Medical SA Company Overview
    • The Feinstein Institute for Medical Research Company Overview
    • Trifectas Medical Corp. Company Overview
    • tVNS Technologies GmbH Company Overview
    • University of Alabama Company Overview
    • University of Auckland Company Overview
    • University of Pittsburgh Company Overview
    • University of Wisconsin Madison Company Overview
    • West Virginia University Company Overview
    • Jul 10, 2024: Setpoint Medical Announces Positive Topline Results from Landmark Reset-Ra Study Evaluating Neuroimmune Modulation for the Treatment of Rheumatoid Arthritis
    • Jul 10, 2024: SetPoint Medical Announces Positive Topline Results from Landmark RESET-RA Study Evaluating Neuroimmune Modulation for the Treatment of Rheumatoid Arthritis
    • Jun 06, 2024: LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
    • Mar 21, 2024: SetPoint Medical Accepted into FDA Total Product Life Cycle Advisory Program for Development of its Neuroimmune Modulation Platform for the Treatment of Multiple Sclerosis
    • Mar 19, 2024: Tampa General Conducts First Procedure on the West Coast of Florida With Device Designed to Revive Arm Function After Stroke
    • Mar 13, 2024: SetPoint wins second FDA breakthrough device nod for neurostim device
    • Mar 13, 2024: SetPoint Medical Receives FDA Breakthrough Device Designation for its Neuroimmune Modulation Platform for the Treatment of Multiple Sclerosis
    • Mar 04, 2024: LivaNova to Present at the Barclays Global Healthcare Conference
    • Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
    • Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
    • Feb 23, 2024: Breakthrough Stroke Treatment at Penn State Health Offers Patients New Hope
    • Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • Dec 26, 2023: electroCore Expands Intellectual Property Portfolio
    • Nov 15, 2023: Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023
    • Oct 24, 2023: TIME Picks MicroTransponder's Vivistim Paired VNS System for 2023 Best Inventions List in Medical Care Category
    • Oct 17, 2023: electroCore Announces Two-Year Extension of gammaCore Device Listing in the NHS Supply Chain Catalogue
    • Oct 11, 2023: electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology
    • Oct 03, 2023: SetPoint Medical Announces Publication of Data for Neuroimmune Modulation to Treat Crohn's Disease in Journal of Crohn's and Colitis
    • Sep 14, 2023: ReShape Lifesciences Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation Device
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us